文献速递牙周病

经验性或微生物指导下的全身抗菌药辅助非手术治疗牙周炎:系统综述

Empirical or microbiologically guided systemic antimicrobials as adjuncts to non-surgical periodontal therapy? A systematic review.
PubMed 文献 · J Clin Periodontol · 2019-01-01

该系统综述旨在回答牙周炎患者接受非手术治疗的辅助全身抗菌药时,临床获益是否取决于治疗前牙周致病菌的检测。检索四个电子数据库的随机对照试验,最终纳入5篇,其中4篇适合固定效应两阶段个体参与者数据荟萃分析。结果显示辅助阿莫西林和甲硝唑在探诊深度减少上优于安慰剂,但根据伴放线聚集杆菌检测未见显著差异。

要点

  • 辅助阿莫西林和甲硝唑在探诊深度减少上优于安慰剂。
  • 基线伴放线聚集杆菌检测对PPD≥5mm的疗效无显著影响。
  • 基线微生物检测不应作为开具辅助抗菌药的指征。

核心结论

  • 没有证据表明基线牙周致病菌检测应作为开具辅助抗菌药的标准,尽管可分析的微生物数据和特定抗菌药信息有限。

研究设计与样本

  • 系统综述,检索四个电子数据库的随机对照试验,初始检索643篇,最终纳入5篇,其中4篇适合固定效应两阶段个体参与者数据荟萃分析并校正基线数据。

主要发现

  • 辅助阿莫西林和甲硝唑在探诊深度减少上优于安慰剂。
  • 根据伴放线聚集杆菌检测,对PPD≥5mm的加权均数差为1.16(95%CI [-5.37, 7.68],I²=37.8%),无显著差异。
  • 其他临床结局根据微生物检测亦无显著差异。
  • 所有纳入研究偏倚风险低。

关键数值与推荐

  • 辅助阿莫西林和甲硝唑在探诊深度减少上优于安慰剂。
  • 伴放线聚集杆菌检测对PPD≥5mm的WMD=1.16(95%CI [-5.37, 7.68],I²=37.8%),无显著差异。

临床怎么用

  • 临床不应仅根据基线牙周致病菌检测结果来决定是否开具辅助全身抗菌药。

局限性

  • 可分析的微生物数据和特定抗菌药信息有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unclear whether patients with specific subgingival microbiological profiles benefit more from adjunctive systemic antibiotics. AIMS: To answer the question: "What is the clinical benefit in periodontitis patients taking adjunctive systemic antimicrobials to non-surgical therapy, depending on pre-treatment detection of periodontopathogenic bacteria?" MATERIALS AND METHODS: A search was conducted in four electronic databases for randomized controlled trials reporting clinical outcomes following adjunctive antibiotic therapy for patients divided by baseline microbiological profiles. RESULTS: The initial search resulted in 643 papers, reduced to five after screening and author contact. Four of these studies were suitable for a fixed effects two-stage individual participant data meta-analysis adjusted for baseline data. Collectively, adjunctive amoxicillin and metronidazole yielded superior clinical results (measured as reduction of PPDs) compared to placebo. No significant differences were detected for the effect of adjunctive antibiotics by the detection of Aggregatibacter actinomycetemcomitans on PPDs ≥ 5 mm (WMD = 1.16, 95% CI [-5.37, 7.68], I2 = 37.8%) or other clinical outcomes. All included studies had low risk of bias. CONCLUSION: There is no evidence to suggest that baseline detection of periodontopathogenic bacteria should be used as criterion for prescribing adjunctive antibiotics, although only limited information on microbial data and specific antimicrobials was available for analysis.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Nibali L, Koidou VP, Hamborg T, et al. Empirical or microbiologically guided systemic antimicrobials as adjuncts to non-surgical periodontal therapy? A systematic review. J Clin Periodontol. 2019. PMID: 31254278. doi:10.1111/jcpe.13164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。